From National Community Pharmacists Association website, published April 4: The Federal Trade Commission (FTC) is soliciting public input on the ways that practices by large, vertically integrated PBMs are affecting drug affordability and access. Pharmacists can share with the agency how PBMs harm consumers and patients. Comments are due April 25.
The National Community Pharmacists Association (NCPA) urges pharmacists to share stories with the FTC about how PBM actions have harmed consumers. NCPA has created a template to tell how anticompetitive activities have caused problems for pharmacists and patients, along with hints to personalize comments.
Print Page
Email to a Friend